← All trials
NCT03764228
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2018
- Primary completion
- Oct 30, 2019
- Completion date
- May 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 27
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peking UniversityLead sponsor
- Peking UniversityReponsible party - principal investigator
- Peking UniversityOverall official - principal investigator
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.